Skip NavigationSkip to Content

Diazonamide A and a synthetic structural analog: Disruptive effects on mitosis and cellular microtubules and analysis of their interactions with tubulin

  1. Author:
    Cruz-Monserrate, Z.
    Vervoort, H. C.
    Bai, R. L.
    Newman, D. J.
    Howell, S. B.
    Los, G.
    Mullaney, J. T.
    Williams, M. D.
    Pettit, G. R.
    Fenical, W.
    Hamel, E.
  2. Author Address

    NCI, Screening Technol Branch, NIH, Bldg 469,Room 104, Frederick, MD 21702 USA NCI, Screening Technol Branch, NIH, Frederick, MD 21702 USA NCI, Nat Prod Branch, Dev Therapeut Program, Div Canc Treatment & Diag,NIH, Frederick, MD 21702 USA Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA Arizona State Univ, Dept Chem & Biochem, Tempe, AZ USA Arizona State Univ, Canc Res Inst, Tempe, AZ USA Hamel E NCI, Screening Technol Branch, NIH, Bldg 469,Room 104, Frederick, MD 21702 USA
    1. Year: 2003
  1. Journal: Molecular Pharmacology
    1. 63
    2. 6
    3. Pages: 1273-1280
  2. Type of Article: Article
  1. Abstract:

    The marine ascidian Diazona angulata was the source organism for the complex cytotoxic peptide diazonamide A. The molecular structure of this peptide was recently revised after synthesis of a biologically active analog of diazonamide A in which a single nitrogen atom was replaced by an oxygen atom. Diazonamide A causes cells to arrest in mitosis, and, after exposure to the drug, treated cells lose both interphase and spindle microtubules. Both diazonamide A and the oxygen analog are potent inhibitors of microtubule assembly, equivalent in activity to dolastatin 10 and therefore far more potent than dolastatin 15. This inhibition of microtubule assembly is accompanied by potent inhibition of tubulin-dependent GTP hydrolysis, also comparable with the effects observed with dolastatin 10. However, the remaining biochemical properties of diazonamide A and its analog differ markedly from those of dolastatin 10 and closely resemble the properties of dolastatin 15. Neither diazonamide A nor the analog inhibited the binding of [H-3] vinblastine, [H-3] dolastatin 10, or [8-C-14] GTP to tubulin. Nor were they able to stabilize the colchicine binding activity of tubulin. These observations indicate either that diazonamide A and the analog have a unique binding site on tubulin differing from the vinca alkaloid and dolastatin 10 binding sites, or that diazonamide A and the analog bind weakly to unpolymerized tubulin but strongly to microtubule ends. If the latter is correct, diazonamide A and its oxygen analog should have uniquely potent inhibitory effects on the dynamic properties of microtubules.

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel